Good to see the analysts asking the important questions.
Why is the ramp up period rollout number confidential? It's Lovenox. Not a new drug. There's no advantage to Sanofi to keeping ramp up numbers confidential. They're only replacing the syringe type!
Alan seemed jittery over the 'upto 2024' question when it was suggested that the deal might not be long term.
Looking forward to seeing the next deal asap. Hopefully it has greater clarity than the Sanofi deal.
conference call, page-11
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)